Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan
Not Applicable
Not yet recruiting
- Conditions
- Healthy Subjects
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Envivo Bio Inc
- Target Recruit Count
- 44
- Registration Number
- NCT07054593
- Locations
- 🇺🇸
Silicon Valley Gastroenterology, Mountain View, California, United States
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
Phase 1
Recruiting
- Conditions
- Small Intestinal Bacterial Overgrowth
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Envivo Bio Inc
- Target Recruit Count
- 34
- Registration Number
- NCT06298409
- Locations
- 🇺🇸
Silicon Valley Gastroenterology, Mountain View, California, United States
Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine
Not Applicable
Completed
- Conditions
- Healthy
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Envivo Bio Inc
- Target Recruit Count
- 10
- Registration Number
- NCT05749068
- Locations
- 🇺🇸
Silicon Valley Gastroenterology, Mountain View, California, United States
News
No news found